May 25, 2011

Many people who provide care and support to loved ones said they are more likely to be nonadherent to their own personal medication regimen than to neglect providing medications to those they are caring for, according to a new study by researchers at Harvard University, Brigham and Women's Hospital and CVS Caremark.

May 25, 2011

UCB announced that it will add two members to its executive committee, effective July 1.

May 24, 2011

Drug maker Eli Lilly is partnering with two private investor groups to form a new biotech company based in central Indiana, the company said Monday.

May 24, 2011

Several states are cutting funding to programs that provide HIV medications to people who can’t afford them in an effort to reduce spending, according to a published report.

May 24, 2011

A drug made by Daiichi-Sankyo was safe and effective in maintaining reductions in blood pressure in older patients, according to a new study presented at the American Society of Hypertension’s 26th annual meeting in New York.

May 23, 2011

The Food and Drug Administration has approved a treatment for hepatitis C made by Vertex Pharmaceuticals, the agency said Monday.

May 23, 2011

The FDA has approved a new treatment for Type 2 diabetes, the agency said. The FDA announced the approval of Tradjenta (linagliptin) made by Indianapolis-based Eli Lilly and German drug maker Boehringer Ingelheim.


May 23, 2011

The Food and Drug Administration has approved a Pfizer drug for treating pancreatic tumors.

May 20, 2011

The Food and Drug Administration has approved a new antiretroviral treatment for HIV made by Johnson & Johnson, the agency said Friday.

May 20, 2011

A Food and Drug Administration advisory committee has voted to recommend that the FDA retain approval of an Abbott drug for high cholesterol in combination with a statin.

May 19, 2011

A controversial GlaxoSmithKline drug for treating Type 2 diabetes no longer will be available through retail pharmacies as of Nov. 18, the Food and Drug Administration announced Wednesday.

May 19, 2011

A drug for cardiovascular disease made by Boehringer Ingelheim has received preferred formulary status with AARP’s Medicare Part D plans, the drug maker said Thursday.

May 19, 2011

Despite the promise of oral drugs for treating cancer, high costs and the burden of taking multiple medications drive 10% of patients prescribed the drugs not to fill their initial prescriptions, according to a new study published in the Journal of Oncology Practice and the American Journal of Managed Care.

May 18, 2011

Global spending on medicines will reach nearly $1.1 trillion by 2015, according to a new study by market research firm IMS Health.

May 18, 2011

Cancer drugs are expected to see sharp increases in spending and use by 2013, according to the latest drug trend report by pharmacy benefit manager Medco Health Solutions.

May 18, 2011

A branded drug made by Watson Pharmaceuticals reduced symptoms in men with prostate disease, according to results of a mid-stage clinical trial.

May 18, 2011

A cancer drug made by Amgen reduced the chances of prostate cancer spreading to the bones, according to results of a late-stage clinical trial presented at the American Urological Association’s annual meeting in Washington.

May 16, 2011

Amylin Pharmaceuticals filed suit against Eli Lilly in federal court Monday concerning an agreement between the latter and German drug maker Boehringer Ingelheim to develop drugs for diabetes.

May 16, 2011

Drug maker Eli Lilly has launched what it’s calling an “umbrella” for its patient assistance programs.

May 16, 2011

Drug maker Eli Lilly will present data from more than 30 studies at the American Society of Clinical Oncology’s annual meeting in Chicago next month, the company said Monday.

May 16, 2011

Drug maker Merck has completed its acquisition of eye care company Inspire.

May 16, 2011

The Food and Drug Administration has approved a new treatment for chronic hepatitis C, the agency said Friday.

May 13, 2011

More than 800 drugs are in development for diseases that affect women, according to a pharmaceutical industry lobbying group.

May 13, 2011

Patients taking cardiovascular drugs may become less adherent if they have to see multiple physicians and make frequent trips to the pharmacy, according to a new study published in the journal Archives of Internal Medicine.